MMPs, tyrosine kinase signaling and extracellular matrix proteolysis in kidney cancer.
Urol Oncol
; 39(6): 316-321, 2021 06.
Article
em En
| MEDLINE
| ID: mdl-32487351
Patients diagnosed with metastatic renal cell carcinoma (RCC) have â¼12% chance for 5-year survival. The integrity of the extracellular matrix (ECM) that surrounds tumor cells influences their behavior and, when disturbed, it could facilitate local invasion and spread of tumor cells to distant sites. The interplay between von Hippel-Lindau/hypoxia inducible factor signaling axis and activated kinase networks results in aberrant ECM and tumor progression. Matrix metalloproteinases (MMPs) are proteolytic enzymes implicated in ECM remodeling, tumor angiogenesis, and immune cell infiltration. Understanding the cross-talk between kinase signaling and ECM proteolysis in RCC could provide insights into developing drugs that interfere specifically with the process of invasion. In this review, we discuss changes in the MMPs/ECM axis in RCC, prominent kinase signaling pathways implicated in MMPs induction, and comment on emerging extracellular regulatory networks that modulate MMPs activity.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Proteínas Tirosina Quinases
/
Carcinoma de Células Renais
/
Metaloproteinases da Matriz
/
Matriz Extracelular
/
Proteólise
/
Neoplasias Renais
Limite:
Humans
Idioma:
En
Revista:
Urol Oncol
Ano de publicação:
2021
Tipo de documento:
Article